ReWalk Robotics Ltd. Expected to Earn FY2028 Earnings of $3.15 Per Share (NASDAQ:LFWD)

ReWalk Robotics Ltd. (NASDAQ:LFWD) – Analysts at HC Wainwright issued their FY2028 earnings per share estimates for ReWalk Robotics in a research report issued on Monday, April 15th. HC Wainwright analyst S. Ramakanth expects that the company will earn $3.15 per share for the year. HC Wainwright has a “Buy” rating and a $9.00 price objective on the stock. The consensus estimate for ReWalk Robotics’ current full-year earnings is ($1.82) per share.

ReWalk Robotics (NASDAQ:LFWD) last announced its quarterly earnings data on Tuesday, February 27th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.91) by $0.56. The business had revenue of $6.88 million for the quarter, compared to analysts’ expectations of $7.20 million. ReWalk Robotics had a negative return on equity of 28.19% and a negative net margin of 159.76%.

ReWalk Robotics Stock Up 0.2 %

NASDAQ:LFWD opened at $5.00 on Wednesday. The company has a fifty day simple moving average of $5.57. The stock has a market capitalization of $42.50 million, a price-to-earnings ratio of -1.74 and a beta of 1.99. ReWalk Robotics has a 12 month low of $3.90 and a 12 month high of $9.10.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.